Injection innovation for safety, equity, and access – at a disruptive price.
 

The Best-Kept Secret in Medical Plastics

 
 
rommelag-4.jpg

A TRUSTED MANUFACTURING PROCESS

• • • • • • • • • • • • • •

50 billion times a year, many of the world’s largest medical brands trust the Blow-Fill-Seal manufacturing process (BFS) to fill sterile containers with eye drops, nose sprays, and even oral vaccines (in ampoules).

See How BFS Works Here
 
 
Blowing_no background copy.png

BLOW


A length of molten plastic is extruded from a machine and a jet of air blows an opening into it, forming a tube which is then sealed at the bottom.
Filling_no background.png

FILL


In a faction of a second, a long needle-like nozzle fills the molten tube with medicine in precisely the dose needed.
Sealing_no background.png

SEAL


Once the nozzle is removed, the tube container is sealed at the top and cooled almost instantly.
ManufacturingBG.png
Roman_1204_with shadow copy.jpg

ANY SHAPE — FAST AND AFFORDABLE

• • • • • • • • • • • • • •

BFS can create an infinite number of container shapes, allowing for unique designs to fit specific needs or marketing campaigns.

A single BFS machine can produce 34,000 ApiJect devices an hour and 275 million doses a year. Plus, its simple manufacturing process enables deliveries on short timetables.

To learn more about Rommelag, the leader in BFS, click here.

 
Roman_1198_with shadow.jpg

SINGLE-DOSE IN INDIVIDUAL UNITS OR STRIPS.

• • • • • • • • • • • • • •

ApiJect devices are delivered in individual units, or strips which can be easily broken apart for quick use or transport in a bag or pocket.

When stacked interlocking for shipment, they take up slightly more room than a multi-dose vial. However, the ApiJect device requires significantly less space than the traditional package: a multi-dose vial + reusable syringes.

 
ApiJect World Map-redone-crop.png

WORLDWIDE NETWORK OF MANUFACTURERS

• • • • • • • • • • • • • •

The components that make up a ApiJect device are produced by multiple manufacturing partners across the globe.

At launch, needle hubs will be produced in South Korea and India. BFS production and final assembly + packaging will take place in Switzerland, South Korea, or at the pharmaceutical company’s plant.

 
rommelag-3.png

LESS ENERGY. LESS WASTE.

• • • • • • • • • • • • • •

The BFS manufacturing process requires significantly less energy than glass manufacturing.

What’s more, a compact ApiJect creates less medical waste than a reusable syringe + glass vial. And, there is no broken glass to worry about.